Insider Trading activities of Boston Scientific Corp insiders. , Part 5

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Boston Scientific Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Boston Scientific Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Boston Scientific Corp since 2005. The reporting company's ticker symbol is BSX. The reporting company's CIK number is 885725.
The total value of stock buying since 2005 is $23,764,032.
The total value of stock sales since 2005 is $883,222,698.
The total value of stock option exercises since 2005 is $82,171,241.



Table 2. Detailed insider stock purchases, sales, and option exercises of Boston Scientific Corp insiders (BSX) , Part 5
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-02-28 Carruthers Wendy (SVP, Human Resources) Option Ex 2,793 .00 0
2013-02-28 Pierce David A (SVP and President, Endoscopy) Option Ex 3,491 .00 0
2013-02-28 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,269 .00 0
2013-02-28 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 4,888 .00 0
2013-02-28 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 3,491 .00 0
2013-02-28 Phalen Michael P. (EVP & President, MedSurg) Option Ex 8,379 .00 0
2013-02-28 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,190 .00 0
2013-02-28 Onuscheck John Michael (SVP & President, EMEA) Option Ex 5,237 .00 0
2013-02-28 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 10,474 .00 0
2013-02-28 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 10,474 .00 0
2013-02-28 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 10,474 .00 0
2013-02-27 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 2,388 .00 0
2013-02-27 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 3,184 .00 0
2013-02-27 Carruthers Wendy (SVP, Human Resources) Option Ex 4,617 .00 0
2013-02-27 Bose Supratim (EVP & President, Asia-Pacific) Option Ex 3,184 .00 0
2013-02-27 Mahoney Michael F (President & CEO) Option Ex 57,324 .00 0
2013-02-27 Pierce David A (SVP and President, Endoscopy) Option Ex 7,165 .00 0
2013-02-27 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 6,369 .00 0
2013-02-27 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 8,758 .00 0
2013-02-27 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 9,952 .00 0
2013-02-27 Phalen Michael P. (EVP & President, MedSurg) Option Ex 10,350 .00 0
2013-02-27 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 7,961 .00 0
2013-02-27 Onuscheck John Michael (SVP & President, EMEA) Option Ex 7,961 .00 0
2013-02-27 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 13,535 .00 0
2013-02-27 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 13,535 .00 0
2013-02-27 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 18,312 .00 0
2013-02-24 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 3,012 .00 0
2013-02-24 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 3,146 .00 0
2013-02-24 Carruthers Wendy (SVP, Human Resources) Option Ex 3,012 .00 0
2013-02-24 Pierce David A (SVP and President, Endoscopy) Option Ex 3,012 .00 0
2013-02-24 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,109 .00 0
2013-02-24 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 2,410 .00 0
2013-02-24 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 1,326 .00 0
2013-02-24 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,699 .00 0
2013-02-24 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,012 .00 0
2013-02-24 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 3,012 .00 0
2013-02-24 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 3,012 .00 0
2013-02-24 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 3,012 .00 0
2013-02-23 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 8,065 .00 0
2013-02-16 Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) Option Ex 11,471 .00 0
2013-02-16 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 11,471 .00 0
2013-02-16 Carruthers Wendy (SVP, Human Resources) Option Ex 4,359 .00 0
2013-02-16 Pierce David A (SVP and President, Endoscopy) Option Ex 5,122 .00 0
2013-02-16 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,116 .00 0
2013-02-16 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 3,374 .00 0
2013-02-16 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 4,724 .00 0
2013-02-16 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,724 .00 0
2013-02-16 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,589 .00 0
2013-02-16 Onuscheck John Michael (SVP & President, EMEA) Option Ex 5,061 .00 0
2013-02-16 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 28,435 .00 0
2013-02-16 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 6,748 .00 0
2013-02-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 20,244 .00 0
2013-02-12 Ballinger Kevin J. (SVP & Pres, Interven Cardio) Option Ex 5,913 .00 0
2013-02-12 Carruthers Wendy (SVP, Human Resources) Option Ex 2,639 .00 0
2013-02-12 Pierce David A (SVP and President, Endoscopy) Option Ex 3,214 .00 0
2013-02-12 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 5,393 .00 0
2013-02-12 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 2,000 .00 0
2013-02-12 Phalen Michael P. (EVP & President, MedSurg) Option Ex 3,278 .00 0
2013-02-12 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,198 .00 0
2013-02-12 Onuscheck John Michael (SVP & President, EMEA) Option Ex 3,996 .00 0
2013-02-12 Pucel Kenneth (EVP, Glob Ops, Qual & Tech) Option Ex 4,794 .00 0
2013-01-07 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 10,775 .00 0
2013-01-03 Bose Supratim (EVP & President, Asia-Pacific) Option Ex 14,925 .00 0
2012-11-13 Nicholas Nj Jr (Director) Buy 20,000 5.28 105,600
2012-11-09 Nicholas Nj Jr (Director) Buy 25,000 5.17 129,299
2012-11-01 Mahoney Michael F (President & CEO) Option Ex 341,669 .00 0
2012-10-30 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 4,580 .00 0
2012-10-30 Onuscheck John Michael (SVP & President, EMEA) Option Ex 2,290 .00 0
2012-09-07 Spriggs Otha T. Iii (SVP, Human Resources) Option Ex 7,198 .00 0
2012-08-06 Mario Ernest (Director) Buy 32,000 5.29 169,280
2012-07-31 Mahoney Michael F (President) Buy 22,000 5.19 114,136
2012-07-31 Onuscheck John Michael (SVP & President, EMEA) Option Ex 3,118 .00 0
2012-07-31 Kucheman William (Chief Executive Officer) Buy 10,000 5.21 52,089
2012-07-29 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 6,667 .00 0
2012-07-29 Onuscheck John Michael (SVP & President, EMEA) Option Ex 4,167 .00 0
2012-07-28 Pierce David A (SVP and President, Endoscopy) Option Ex 234 .00 0
2012-06-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 14,662 .00 0
2012-05-12 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 7,236 .00 0
2012-05-10 Neumann Lawrence R (SVP, Special Projects) Option Ex 1,288 .00 0
2012-05-07 Onuscheck John Michael (SVP & President, EMEA) Option Ex 2,350 .00 0
2012-05-01 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 14,750 .00 0
2012-02-28 Neumann Lawrence R (SVP, Special Projects) Option Ex 5,238 .00 0
2012-02-28 Pierce David A (SVP and President, Endoscopy) Option Ex 3,492 .00 0
2012-02-28 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,270 .00 0
2012-02-28 Spriggs Otha T. Iii (SVP, Human Resources) Option Ex 4,540 .00 0
2012-02-28 Dawkins Keith D (EVP, Global Chief Med. Off.) Option Ex 4,889 .00 0
2012-02-28 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 3,492 .00 0
2012-02-28 Phalen Michael P. (EVP & President, MedSurg) Option Ex 8,380 .00 0
2012-02-28 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,190 .00 0
2012-02-28 Onuscheck John Michael (SVP & President, EMEA) Option Ex 5,238 .00 0
2012-02-28 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 10,475 .00 0
2012-02-28 Kucheman William (Chief Executive Officer) Option Ex 13,967 .00 0
2012-02-28 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 10,475 .00 0
2012-02-28 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 7,682 .00 0
2012-02-28 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 10,475 .00 0
2012-02-24 Neumann Lawrence R (SVP and Pres, Emerging Markets) Option Ex 4,217 .00 0
2012-02-24 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,109 .00 0
2012-02-24 Dawkins Keith D (Sr. VP, Global Chief Med. Off.) Option Ex 2,410 .00 0
2012-02-24 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 1,760 3.12 5,500
2012-02-24 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,699 .00 0
2012-02-24 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,012 .00 0
2012-02-24 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 3,012 .00 0
2012-02-24 Kucheman William (Chief Executive Officer) Option Ex 3,012 .00 0
2012-02-24 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 3,012 .00 0
2012-02-24 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 3,615 .00 0
2012-02-24 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 3,012 .00 0
2012-02-23 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 8,064 .00 0
2012-02-23 Mario Ernest (Director) Buy 10,000 5.91 59,100
2012-02-22 Mario Ernest (Director) Buy 10,000 5.93 59,300
2012-02-21 Mario Ernest (Director) Buy 20,000 6.12 122,400
2012-02-16 Neumann Lawrence R (SVP and Pres, Emerging Markets) Option Ex 4,943 .00 0
2012-02-16 Pierce David A (SVP and President, Endoscopy) Option Ex 5,121 .00 0
2012-02-16 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,115 .00 0
2012-02-16 Dawkins Keith D (Sr. VP, Global Chief Med. Off.) Option Ex 3,373 .00 0
2012-02-16 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 4,723 .00 0
2012-02-16 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 4,048 .00 0
2012-02-16 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,723 .00 0
2012-02-16 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,588 .00 0
2012-02-16 Onuscheck John Michael (SVP & President, EMEA) Option Ex 5,060 .00 0
2012-02-16 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 28,434 .00 0
2012-02-16 Kucheman William (Chief Executive Officer) Option Ex 13,495 .00 0
2012-02-16 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 6,747 .00 0
2012-02-16 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 6,747 .00 0
2012-02-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 20,242 .00 0
2012-02-13 Pierce David A (SVP and President, Endoscopy) Option Ex 1,605 .00 0
2012-02-13 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 1,638 .00 0
2012-02-13 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 2,923 .00 0
2012-02-13 Onuscheck John Michael (SVP & President, EMEA) Option Ex 1,638 .00 0
2012-02-12 Neumann Lawrence R (SVP and Pres, Emerging Markets) Option Ex 2,955 .00 0
2012-02-12 Pierce David A (SVP and President, Endoscopy) Option Ex 3,210 .00 0
2012-02-12 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 5,391 .00 0
2012-02-12 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 1,996 .00 0
2012-02-12 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 998 .00 0
2012-02-12 Phalen Michael P. (EVP & President, MedSurg) Option Ex 3,274 .00 0
2012-02-12 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,194 .00 0
2012-02-12 Onuscheck John Michael (SVP & President, EMEA) Option Ex 3,993 .00 0
2012-02-12 Kucheman William (Chief Executive Officer) Option Ex 3,993 .00 0
2012-02-12 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 4,792 .00 0
2012-02-12 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 3,993 .00 0
2012-01-07 Dawkins Keith D (Sr. VP, Chief Medical Officer) Option Ex 10,771 .00 0
2011-12-31 Elliott John Raymond Option Ex 333,333 .00 0
2011-11-29 Nicholas Nj Jr (Director) Buy 10,000 5.56 55,599
2011-11-28 Bartlett Katharine T (Director) Buy 8,000 5.42 43,360
2011-11-28 Mario Ernest (Director) Buy 100,000 5.40 540,000
2011-11-21 Mario Ernest (Director) Buy 25,000 5.30 132,500
2011-11-14 Connors Nelda J (Director) Sale 2,500 5.84 14,600
2011-11-04 Pierce David A (SVP and President, Endoscopy) Sale 15,869 5.77 91,548
2011-10-31 Kucheman William (Chief Executive Officer) Option Ex 6,500 .00 0
2011-10-31 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 6,500 .00 0
2011-10-30 Nanavaty Maulik (SVP & President, Neuromodula) Option Ex 4,580 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of BSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Boston Scientific Corp (symbol BSX, CIK number 885725) see the Securities and Exchange Commission (SEC) website.